Globavend is trading at $0.93, up +8.87% in pre-market; no company-specific announcement explaining the October 23 move was identified. - The latest identified company release concerned its October 15 ThinkEquity presentation. - Globavend fell 11.47% to $0.85 on October 22, per the supplied price context. - Friday’s broader market was mixed, with US futures near flat after the prior session’s technology selloff; this does not establish the cause of Globavend’s gain.